Department of Defense officials announced yesterday that Chelsea Manning, the former intelligence analyst who leaked classified documents to WikiLeaks, has been approved for the hormone treatment by the Department of Defense.
Defense Department officials said Thursday that the hormone therapy was approved Feb. 5 by Col. Erica Nelson, commandant of the U.S. Disciplinary Barracks at Fort Leavenworth, Kansas, where Manning is serving a 35-year sentence.
The treatment would enable the Army private formerly known as Bradley Manning to make the transition to a woman. Manning changed her legal name in April 2014.
DOD officials revealed the information on the condition of anonymity, as they were not authorized to speak about the matter.
The decision came after a lawsuit was filed in September in U.S. District Court for the District of Columbia. It alleged Manning was at a high risk of self-castration and suicide unless she received more focused treatment for gender dysphoria, the sense of being a woman in a man’s body.
“But the delay in treatment came with a significant cost to Chelsea and her mental health and we are hopeful that the government continues to meet Chelsea’s medical needs as is its obligation under the Constitution so that those harms may be mitigated,” said Chase Strangio, an attorney with the ACLU and counsel for Manning said in a statement.